Stay updated on AMX0035 in ALS: Phoenix Clinical Trial
Sign up to get notified when there's something new on the AMX0035 in ALS: Phoenix Clinical Trial page.

Latest updates to the AMX0035 in ALS: Phoenix Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed. No other content changes.SummaryDifference0.2%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%
- Check17 days agoChange DetectedThe web page has been updated to include new drug information and resources related to Sodium Phenylbutyrate and Amyotrophic Lateral Sclerosis, while also changing the facility name and location details.SummaryDifference3%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check46 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to AMX0035 in ALS: Phoenix Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AMX0035 in ALS: Phoenix Clinical Trial page.